Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Japon400
Yoshikuni Mizuno28
Japon Sauf Yoshikuni Mizuno" 372
Yoshikuni Mizuno Sauf Japon" 0
Japon Et Yoshikuni Mizuno 28
Japon Ou Yoshikuni Mizuno 400
Corpus10303
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 28.
Ident.Authors (with country if any)Title
000719 Yoshikuni Mizuno [Japon] ; Masahiro Nomoto ; Tomoyoshi Kondo ; Kazuko Hasegawa ; Miho Murata ; Masahiro Takeuchi ; Junji Ikeda ; Takayuki Tomida ; Nobutaka HattoriTransdermal rotigotine in early stage Parkinson's disease: a randomized, double-blind, placebo-controlled trial.
000932 Saori Miyakawa [Japon] ; Mieko Ogino ; Sayaka Funabe ; Akiko Uchino ; Yasushi Shimo ; Nobutaka Hattori ; Masaaki Ichinoe ; Tetuo Mikami ; Makoto Saegusa ; Kazutoshi Nishiyama ; Hideo Mori ; Yoshikuni Mizuno ; Shigeo Murayama ; Hideki MochizukiLewy body pathology in a patient with a homozygous parkin deletion.
000B14 Yoshikuni Mizuno [Japon] ; Tomoyoshi Kondo [Japon]Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson’s disease
001563 Thomas Gasser [Allemagne] ; John Hardy [Royaume-Uni] ; Yoshikuni Mizuno [Japon]Milestones in PD genetics
001A63 Anthony H. V. Schapira [Royaume-Uni] ; Stefan Albrecht [Allemagne] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis]Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study
001A66 Manabu Funayama [Japon] ; Hiroyuki Tomiyama [Japon] ; Ruey-Meei Wu [Taïwan] ; Kotaro Ogaki [Japon] ; Hiroyo Yoshino [Japon] ; Yoshikuni Mizuno [Japon] ; Nobutaka Hattori [Japon]Rapid screening of ATP13A2 variant with high‐resolution melting analysis
001A67 Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche]Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
001D19 Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease
001D94 Yoshikuni Mizuno [Japon] ; Kazuko Hasegawa [Japon] ; Tomoyoshi Kondo [Japon] ; Sadako Kuno [Japon] ; Mitsutoshi Yamamoto [Japon]Clinical efficacy of istradefylline (KW‐6002) in Parkinson's disease: A randomized, controlled study
002313 Kenya Nishioka [Japon, États-Unis] ; Owen A. Ross [États-Unis] ; Kenji Ishii [Japon] ; Jennifer M. Kachergus [États-Unis] ; Kiichi Ishiwata [Japon] ; Mayumi Kitagawa [Japon] ; Satoshi Kono [Japon] ; Tomokazu Obi [Japon] ; Koichi Mizoguchi [Japon] ; Yuichi Inoue [Japon] ; Hisamasa Imai [Japon] ; Masashi Takanashi [Japon] ; Yoshikuni Mizuno [Japon] ; Matthew J. Farrer [États-Unis] ; Nobutaka Hattori [Japon]Expanding the clinical phenotype of SNCA duplication carriers
002584 Kazuo Yamashiro [Japon] ; Miki Komine-Kobayashi [Japon] ; Taku Hatano [Japon] ; Takao Urabe [Japon] ; Hideki Mochizuki [Japon] ; Nobutaka Hattori [Japon] ; Yoshitaka Iwama [Japon] ; Hiroyuki Daida [Japon] ; Michi Sakai [Japon] ; Takeo Nakayama [Japon] ; Yoshikuni Mizuno [Japon]The frequency of cardiac valvular regurgitation in Parkinson's disease
002747 Hiroyuki Tomiyama [Japon] ; Yasumasa Kokubo [Japon] ; Ryogen Sasaki [Japon] ; Yuanzhe Li [Japon] ; Yoko Imamichi [Japon] ; Manabu Funayama [Japon] ; Yoshikuni Mizuno [Japon] ; Nobutaka Hattori [Japon] ; Shigeki Kuzuhara [Japon]Mutation analyses in amyotrophic lateral sclerosis/parkinsonism–dementia complex of the Kii peninsula, Japan
002846 Manabu Funayama [Japon] ; Yuanzhe Li [Japon] ; Tak-Hong Tsoi [République populaire de Chine] ; Ching-Wan Lam [République populaire de Chine] ; Takekazu Ohi [Japon] ; Shogo Yazawa [Japon] ; Eiichiro Uyama [Japon] ; Ruth Djaldetti [Israël] ; Eldad Melamed [Israël] ; Hiroyo Yoshino [Japon] ; Yoko Imamichi [Japon] ; Hiroshi Takashima [Japon] ; Kenya Nishioka [Japon] ; Kenichi Sato [Japon] ; Hiroyuki Tomiyama [Japon] ; Shin-Ichiro Kubo [Japon] ; Yoshikuni Mizuno [Japon] ; Nobutaka Hattori [Japon]Familial Parkinsonism with digenic parkin and PINK1 mutations
002B94 Yoshikuni Mizuno [Japon] ; Takashi Abe [Japon] ; Kazuko Hasegawa [Japon] ; Sadako Kuno [Japon] ; Tomoyoshi Kondo [Japon] ; Mitsutoshi Yamamoto [Japon] ; Mitsuyoshi Nakashima [Japon] ; Ichiro Kanazawa [Japon]Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study
002C60 Yoshikuni Mizuno [Japon] ; Gregor K. Wenning [Autriche]Preface
002C71 Yoshikuni Mizuno [Japon] ; Ichiro Kanazawa [Japon] ; Sadako Kuno [Japon] ; Nobuo Yanagisawa [Japon] ; Mitsutoshi Yamamoto [Japon] ; Tomoyoshi Kondo [Japon]Placebo‐controlled, double‐blind dose‐finding study of entacapone in fluctuating parkinsonian patients
002E97 Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie]Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
003221 Shin-Ichiro Kubo [Japon] ; Nobutaka Hattori [Japon] ; Yoshikuni Mizuno [Japon]Recessive Parkinson's disease
003242 Kenichi Sato [Japon] ; Taku Hatano [Japon] ; Kazuo Yamashiro [Japon] ; Maki Kagohashi [Japon] ; Kenya Nishioka [Japon] ; Nana Izawa [Japon] ; Hideki Mochizuki [Japon] ; Nobutaka Hattori [Japon] ; Hideo Mori [Japon] ; Yoshikuni Mizuno [Japon]Prognosis of Parkinson's disease: Time to stage III, IV, V, and to motor fluctuations
003527 Hiroyuki Tomiyama [Japon] ; Yuanzhe Li [Japon] ; Manabu Funayama [Japon] ; Kazuko Hasegawa [Japon] ; Hiroyo Yoshino [Japon] ; Shin-Ichiro Kubo [Japon] ; Kenichi Sato [Japon] ; Tatsuya Hattori [Japon] ; Chin-Song Lu [Taïwan] ; Rivka Inzelberg [Israël] ; Ruth Djaldetti [Israël] ; Eldad Melamed [Israël] ; Rim Amouri [Tunisie] ; Neziha Gouider-Khouja [Tunisie] ; Faycal Hentati [Tunisie] ; Yasuko Hatano [Japon] ; Mei Wang [Japon] ; Yoko Imamichi [Japon] ; Koichi Mizoguchi [Japon] ; Hiroaki Miyajima [Japon] ; Fumiya Obata [Japon] ; Tatsushi Toda [Japon] ; Matthew J. Farrer [États-Unis] ; Yoshikuni Mizuno [Japon] ; Nobutaka Hattori [Japon]Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries
003781 Satoshi Orimo [Japon] ; Takeshi Amino [Japon] ; Masayuki Yokochi [Japon] ; Tohru Kojo [Japon] ; Toshiki Uchihara [Japon] ; Atsushi Takahashi [Japon] ; Koichi Wakabayashi [Japon] ; Hitoshi Takahashi [Japon] ; Nobutaka Hattori [Japon] ; Yoshikuni Mizuno [Japon]Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2
003833 Yasuyuki Okuma [Japon] ; Kenji Fujishima [Japon] ; Hideto Miwa [Japon] ; Hideo Mori [Japon] ; Yoshikuni Mizuno [Japon]Myoclonic tremulous movements in multiple system atrophy are a form of cortical myoclonus
003F71 Yoshikuni Mizuno [Japon] ; Nobuo Yanagisawa [Japon] ; Sadako Kuno [Japon] ; Mitsutoshi Yamamoto [Japon] ; Kazuko Hasegawa [Japon] ; Hideki Origasa [Japon] ; Hisayuki Kowa [Japon]Randomized, double‐blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease
004748 Yasuyuki Okuma [Japon] ; Yoshikuni Mizuno [Japon]Myoclonic tremor in patients with parkinsonian‐type multiple system atrophy
004D34 Hideto Miwa [Japon] ; Asako Yoritaka [Japon] ; Yoshikuni Mizuno [Japon]Hemifacial spasm in Parkinson's disease
004D65 Etienne C. Hirsch [France] ; Stéphane Hunot [France] ; Baptiste Faucheux [France] ; Yves Agid [France] ; Yoshikuni Mizuno [Japon] ; Hideki Mochizuki [Japon] ; William G. Tatton [États-Unis] ; Nadine Tatton [États-Unis] ; Warren C. Olanow [États-Unis]Dopaminergic neurons degenerate by apoptosis in Parkinson's disease
005675 Ikeda [Japon] ; Hiroshi Shibasaki [Japon] ; Kunio Tasgiro [Japon] ; Yoshikuni Mizuno [Japon] ; Jun Kimura [Japon]Clinical trial of piracetam in patients with myoclonus: Nationwide multiinstitution study in Japan
005F86 Yoshikuni Mizuno [Japon] ; Shin-Ichirou Ikebe [Japon] ; Nobutaka Hattori [Japon] ; Yuko Nakagawa-Hattori [Japon] ; Masashi Tanaka [Japon] ; Takayuki Ozawa [Japon]Mitochondrial abnormalities in Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024